Shiralizadeh Javad, Barmaki Haleh, Haiaty Sanya, Faridvand Yousef, Mostafazadeh Mostafa, Mokarizadeh Narmin, Kamrani Amir, Isazadeh Alireza, Maroufi Nazila Fathi
Department of Biology, Payam University of Mashhad, Mashhad, Iran.
Department of Laboratory Medicine, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Horm Mol Biol Clin Investig. 2017 Sep 4;33(3):/j/hmbci.2018.33.issue-3/hmbci-2017-0039/hmbci-2017-0039.xml. doi: 10.1515/hmbci-2017-0039.
Objective Oxidants include important active molecules which are created in the body and attack biological molecules especially lipids, carbohydrates, nucleic acids and proteins, and cause oxidation and various diseases in the body. Antioxidants existing in the body help to avoid the incidence of these injuries. Pregnant women are among those where oxidation of biological molecules may do irreparable damage to them and their embryos. So, the purpose of this study was to review the effect of folic acid with both high (5 mg/day) and low (0.5 mg/day) doses on the changes of oxidative protein in reducing plasma homocystein concentration during pregnancy. Materials and methods Forty-five pregnant women participated in this study. They were divided into two groups: group 1 included 23 women who received 5 mg/day folic acid and group 2 included 23 women who took 0.5 mg/day folic acid before pregnancy till the 36th week pregnancy. We measured the biochemical variables in the serum of pregnant women at the beginning and at the end of the study. Results Folic acid reduced plasma homocytein in both low and high dose groups (p = 0.035, p = 0.012, respectively). Also, the results showed that folic acid prescription led to reduce plasma level of carbonyl groups in both low and high dose groups (p = 0.01, p = 0.03, respectively). Furthermore, the results showed that there is no significant difference between two groups and folic acid affects both groups equally. Conclusion It is possible that folic acid administration can reduce plasma homocysteine and carbonyl levels during pregnancy in dose independent manner.
目的 氧化剂包括体内产生的重要活性分子,它们会攻击生物分子,尤其是脂质、碳水化合物、核酸和蛋白质,并在体内引发氧化反应和各种疾病。体内存在的抗氧化剂有助于避免这些损伤的发生。孕妇属于生物分子氧化可能对其自身及其胚胎造成不可修复损害的人群。因此,本研究的目的是探讨高剂量(5毫克/天)和低剂量(0.5毫克/天)叶酸对孕期降低血浆同型半胱氨酸浓度过程中氧化蛋白变化的影响。
材料与方法 45名孕妇参与了本研究。她们被分为两组:第1组包括23名每天服用5毫克叶酸的女性,第2组包括23名在怀孕前至怀孕第36周每天服用0.5毫克叶酸的女性。我们在研究开始和结束时测量了孕妇血清中的生化变量。
结果 低剂量组和高剂量组的叶酸均降低了血浆同型半胱氨酸水平(分别为p = 0.035,p = 0.012)。此外,结果表明,低剂量组和高剂量组的叶酸处方均导致血浆羰基水平降低(分别为p = 0.01,p = 0.03)。此外,结果表明两组之间没有显著差异,叶酸对两组的影响相同。
结论 叶酸给药有可能以剂量无关的方式降低孕期血浆同型半胱氨酸和羰基水平。